These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 1714401

  • 1. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 4. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nagamine D, Shinagawa K, Tabata M, Hirano A, Mizunuma N.
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor.
    Johnsen HE, Hansen PB, Plesner T, Jensen L, Gaarsdal E, Andersen H, Hansen SW, Birgens H, Jacobsen GK, Kjaersgaard E.
    Bone Marrow Transplant; 1992 Sep; 10(3):229-34. PubMed ID: 1384899
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
    Mayer P, Werner FJ, Lam C, Besemer J.
    Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM.
    Cancer Res; 1990 Feb 01; 50(3):606-14. PubMed ID: 2404573
    [Abstract] [Full Text] [Related]

  • 13. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G, Loeffler M, Nijhof W.
    Exp Hematol; 1992 Jun 01; 20(5):600-4. PubMed ID: 1375161
    [Abstract] [Full Text] [Related]

  • 14. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1994 Jan 01; 22(1):100-2. PubMed ID: 7506671
    [Abstract] [Full Text] [Related]

  • 15. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N, Chertkov J, Samoilina N, Zander A.
    Exp Hematol; 1996 Jun 01; 24(7):816-22. PubMed ID: 8647232
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G.
    Exp Hematol; 1997 Sep 01; 25(10):1084-93. PubMed ID: 9293906
    [Abstract] [Full Text] [Related]

  • 17. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H, Ishikawa J, Kitayama H, Yamagami T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F.
    Exp Hematol; 1989 Sep 01; 17(8):853-8. PubMed ID: 2475358
    [Abstract] [Full Text] [Related]

  • 18. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S, Media JE, Nakeff A.
    Stem Cells; 1998 Sep 01; 16(2):144-51. PubMed ID: 9554039
    [Abstract] [Full Text] [Related]

  • 19. In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis.
    Pojda Z, Tanaka K, Aoki Y, Tsuboi A.
    Exp Hematol; 1992 Aug 01; 20(7):874-8. PubMed ID: 1378408
    [Abstract] [Full Text] [Related]

  • 20. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H, Okano A, Suzuki C, Konishi A, Akiyama Y, Ishibashi T, Ozawa K, Asano S.
    Transplantation; 1995 Jun 15; 59(11):1596-600. PubMed ID: 7539959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.